1,2-dimethylhydrazine decreases expression ISO Dclk1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of DCLK1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of DCLK1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCLK1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DCLK1 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DCLK1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of DCLK1 mRNA CTD PMID:19693291 17beta-estradiol increases expression ISO DCLK1 (Homo sapiens) 6480464 Estradiol results in increased expression of DCLK1 mRNA CTD PMID:19619570 and PMID:20106945 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DCLK1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of DCLK1 mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DCLK1 mRNA CTD PMID:19619570 and PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DCLK1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dclk1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DCLK1 mRNA CTD PMID:18343893 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Dclk1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DCLK1 mRNA CTD PMID:15328365 and PMID:23994337 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO DCLK1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of DCLK1 mRNA CTD PMID:19619570 and PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Dclk1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of DCLK1 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCLK1 mRNA CTD PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Dclk1 (Mus musculus) 6480464 2 more ... CTD PMID:18343893 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO DCLK1 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-methylcholine affects expression ISO DCLK1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of DCLK1 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Dclk1 (Mus musculus) 6480464 3 more ... CTD PMID:23994337 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-methylcholanthrene decreases expression ISO Dclk1 (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of DCLK1 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of DCLK1 mRNA CTD PMID:30723492 4-hydroxyphenyl retinamide decreases expression ISO Dclk1 (Mus musculus) 6480464 Fenretinide results in decreased expression of DCLK1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO DCLK1 (Homo sapiens) 6480464 Decitabine affects the expression of DCLK1 mRNA CTD PMID:17145863 5-fluorouracil multiple interactions ISO DCLK1 (Homo sapiens) 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of DCLK1 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DCLK1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of DCLK1 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of DCLK1 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO DCLK1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of DCLK1 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO DCLK1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of DCLK1 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DCLK1 mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin B1 decreases expression ISO DCLK1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of DCLK1 mRNA CTD PMID:22100608 Aflatoxin B2 alpha decreases methylation ISO DCLK1 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of DCLK1 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO Dclk1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of DCLK1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DCLK1 mRNA CTD PMID:16483693 amosite asbestos decreases methylation ISO DCLK1 (Homo sapiens) 6480464 Asbestos and Amosite results in decreased methylation of DCLK1 promoter CTD PMID:29626692 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of DCLK1 mRNA CTD PMID:30779732 amphotericin B decreases expression ISO DCLK1 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of DCLK1 mRNA CTD PMID:28534445 antirheumatic drug increases expression ISO DCLK1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of DCLK1 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO DCLK1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of DCLK1 mRNA CTD PMID:29633893 benzo[a]pyrene decreases expression ISO DCLK1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of DCLK1 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO DCLK1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of DCLK1 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO DCLK1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of DCLK1 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of DCLK1 mRNA CTD PMID:21839799 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DCLK1 mRNA CTD PMID:18164116 beta-naphthoflavone increases expression ISO Dclk1 (Mus musculus) 6480464 beta-Naphthoflavone results in increased expression of DCLK1 mRNA CTD PMID:23994337 bis(2-ethylhexyl) phthalate increases expression ISO DCLK1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of DCLK1 protein CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DCLK1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Dclk1 (Mus musculus) 6480464 bisphenol A results in increased expression of DCLK1 mRNA CTD PMID:30245210 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DCLK1 mRNA CTD PMID:30816183 and PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DCLK1 gene CTD PMID:28505145 bisphenol A increases expression ISO DCLK1 (Homo sapiens) 6480464 bisphenol A results in increased expression of DCLK1 mRNA CTD PMID:27685785 bosentan affects expression ISO DCLK1 (Homo sapiens) 6480464 Bosentan affects the expression of DCLK1 mRNA CTD PMID:29761207 butanal increases expression ISO DCLK1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of DCLK1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of DCLK1 mRNA CTD PMID:19167457 carbon nanotube increases expression ISO Dclk1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 cerium trichloride increases expression ISO Dclk1 (Mus musculus) 6480464 cerous chloride results in increased expression of DCLK1 mRNA CTD PMID:23573234 CGP 52608 multiple interactions ISO DCLK1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to DCLK1 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of DCLK1 protein CTD PMID:34058248 choline multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCLK1 mRNA CTD PMID:20938992 clotrimazole decreases expression EXP 6480464 Clotrimazole results in decreased expression of DCLK1 mRNA CTD PMID:30047161 clozapine increases expression ISO Dclk1 (Mus musculus) 6480464 Clozapine results in increased expression of DCLK1 mRNA CTD PMID:18797397 clozapine increases expression EXP 6480464 Clozapine results in increased expression of DCLK1 mRNA CTD PMID:15860345 copper atom increases expression EXP 6480464 Copper results in increased expression of DCLK1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of DCLK1 mRNA CTD PMID:30556269 coumestrol decreases expression ISO DCLK1 (Homo sapiens) 6480464 Coumestrol results in decreased expression of DCLK1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos decreases expression ISO DCLK1 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of DCLK1 mRNA CTD PMID:25351596 crocidolite asbestos decreases methylation ISO DCLK1 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased methylation of DCLK1 promoter CTD PMID:29626692 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of DCLK1 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO DCLK1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of DCLK1 mRNA CTD PMID:20106945 D-glucose multiple interactions ISO Dclk1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of DCLK1 mRNA CTD PMID:23914054 dexamethasone increases expression ISO DCLK1 (Homo sapiens) 6480464 Dexamethasone results in increased expression of DCLK1 mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO DCLK1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of DCLK1 mRNA CTD PMID:29633893 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of DCLK1 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO Dclk1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCLK1 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of DCLK1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO DCLK1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DCLK1 mRNA CTD PMID:29803840 doxorubicin increases expression ISO DCLK1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of DCLK1 mRNA CTD PMID:30031762 endosulfan multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of DCLK1 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of DCLK1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA CTD PMID:19167446 entinostat multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA CTD PMID:27188386 entinostat decreases expression ISO DCLK1 (Homo sapiens) 6480464 entinostat results in decreased expression of DCLK1 mRNA CTD PMID:27188386 entinostat increases expression ISO DCLK1 (Homo sapiens) 6480464 entinostat results in increased expression of DCLK1 mRNA CTD PMID:26272509 ethanol multiple interactions ISO Dclk1 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of DCLK1 mRNA CTD PMID:30319688 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of DCLK1 mRNA CTD PMID:18035473 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of DCLK1 mRNA CTD PMID:18301726 folic acid multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCLK1 mRNA CTD PMID:20938992 folic acid decreases expression ISO Dclk1 (Mus musculus) 6480464 Folic Acid results in decreased expression of DCLK1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO DCLK1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of DCLK1 mRNA CTD PMID:28937961 fructose multiple interactions ISO Dclk1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 furan increases expression EXP 6480464 furan results in increased expression of DCLK1 mRNA CTD PMID:27387713 genistein increases expression ISO Dclk1 (Mus musculus) 6480464 Genistein results in increased expression of DCLK1 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DCLK1 mRNA CTD PMID:33387578 glucose multiple interactions ISO Dclk1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of DCLK1 mRNA CTD PMID:33150645 glycidol increases methylation EXP 6480464 glycidol results in increased methylation of DCLK1 promoter CTD PMID:33150595 haloperidol increases expression ISO Dclk1 (Mus musculus) 6480464 Haloperidol results in increased expression of DCLK1 mRNA CTD PMID:18797397 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of DCLK1 mRNA CTD PMID:15860345 ivermectin decreases expression ISO DCLK1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of DCLK1 protein CTD PMID:32959892 L-ascorbic acid increases expression ISO Dclk1 (Mus musculus) 6480464 Ascorbic Acid results in increased expression of DCLK1 mRNA CTD PMID:15305145 L-methionine multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DCLK1 mRNA CTD PMID:20938992 lead(0) affects expression ISO DCLK1 (Homo sapiens) 6480464 Lead affects the expression of DCLK1 mRNA CTD PMID:28903495 methylmercury chloride increases expression ISO DCLK1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of DCLK1 mRNA CTD PMID:23179753 and PMID:26272509 methylmercury chloride decreases expression ISO DCLK1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of DCLK1 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA CTD PMID:27188386 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of DCLK1 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression ISO DCLK1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of DCLK1 mRNA CTD PMID:24810058 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DCLK1 mRNA CTD PMID:18164116 nickel atom decreases expression ISO DCLK1 (Homo sapiens) 6480464 Nickel results in decreased expression of DCLK1 mRNA CTD PMID:24768652 olanzapine increases expression ISO Dclk1 (Mus musculus) 6480464 olanzapine results in increased expression of DCLK1 mRNA CTD PMID:18797397 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DCLK1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of DCLK1 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA CTD PMID:27188386 panobinostat increases expression ISO DCLK1 (Homo sapiens) 6480464 panobinostat results in increased expression of DCLK1 mRNA CTD PMID:26272509 paracetamol increases expression ISO DCLK1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of DCLK1 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DCLK1 mRNA CTD PMID:33387578 pentanal increases expression ISO DCLK1 (Homo sapiens) 6480464 pentanal results in increased expression of DCLK1 mRNA CTD PMID:26079696 perfluorononanoic acid increases expression ISO DCLK1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of DCLK1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO DCLK1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of DCLK1 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO DCLK1 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of DCLK1 mRNA CTD PMID:32588087 pirinixic acid increases expression ISO Dclk1 (Mus musculus) 6480464 pirinixic acid results in increased expression of DCLK1 mRNA CTD PMID:20813756 potassium dichromate decreases expression ISO Dclk1 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of DCLK1 mRNA CTD PMID:23608068 progesterone multiple interactions ISO Dclk1 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of DCLK1 mRNA CTD PMID:19693291 propanal increases expression ISO DCLK1 (Homo sapiens) 6480464 propionaldehyde results in increased expression of DCLK1 mRNA CTD PMID:26079696 resveratrol multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in decreased expression of DCLK1 mRNA and [Plant Extracts co-treated with Resveratrol] results in decreased expression of DCLK1 mRNA CTD PMID:19167446 and PMID:23557933 resveratrol increases expression ISO Dclk1 (Mus musculus) 6480464 resveratrol results in increased expression of DCLK1 protein CTD PMID:25505154 SB 431542 multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO DCLK1 (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased methylation of DCLK1 promoter CTD PMID:29626692 silicon dioxide increases expression ISO DCLK1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of DCLK1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Dclk1 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of DCLK1 mRNA CTD PMID:29341224 sodium arsenite increases expression ISO DCLK1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of DCLK1 mRNA CTD PMID:29301061 sodium arsenite affects expression ISO Dclk1 (Mus musculus) 6480464 sodium arsenite affects the expression of DCLK1 mRNA CTD PMID:26674514 sodium arsenite decreases expression ISO DCLK1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of DCLK1 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of DCLK1 mRNA CTD PMID:19281266 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of DCLK1 mRNA CTD PMID:21515302 testosterone decreases expression ISO Dclk1 (Mus musculus) 6480464 Testosterone results in decreased expression of DCLK1 mRNA CTD PMID:19693291 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DCLK1 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO Dclk1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of DCLK1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DCLK1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Dclk1 (Mus musculus) 6480464 titanium dioxide results in increased expression of DCLK1 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DCLK1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of DCLK1 mRNA CTD PMID:25729387 tributylstannane increases expression ISO Dclk1 (Mus musculus) 6480464 tributyltin results in increased expression of DCLK1 mRNA CTD PMID:31939706 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of DCLK1 gene CTD PMID:27618143 trichostatin A decreases expression ISO DCLK1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of DCLK1 mRNA CTD PMID:24935251 trichostatin A increases expression ISO DCLK1 (Homo sapiens) 6480464 trichostatin A results in increased expression of DCLK1 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO Dclk1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of DCLK1 mRNA CTD PMID:19042947 triptonide increases expression ISO Dclk1 (Mus musculus) 6480464 triptonide results in increased expression of DCLK1 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of DCLK1 mRNA CTD PMID:21515302 urethane decreases expression ISO DCLK1 (Homo sapiens) 6480464 Urethane results in decreased expression of DCLK1 mRNA CTD PMID:28818685 valproic acid increases methylation ISO DCLK1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of DCLK1 gene CTD PMID:29154799 valproic acid decreases expression ISO DCLK1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of DCLK1 mRNA CTD PMID:27188386 valproic acid multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA CTD PMID:27188386 valproic acid increases expression ISO DCLK1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of DCLK1 mRNA CTD PMID:23179753 more ... valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of DCLK1 mRNA CTD PMID:29427782 vorinostat decreases expression ISO DCLK1 (Homo sapiens) 6480464 vorinostat results in decreased expression of DCLK1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of DCLK1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO DCLK1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of DCLK1 mRNA CTD PMID:18593933